Cyclerion Therapeutics Inc. (NASDAQ: CYCN) Stock Information | RedChip

Cyclerion Therapeutics Inc. (NASDAQ: CYCN)


$3.2500
+0.0600 ( +0.31% ) 23.4K

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Market Data


Open


$3.2500

Previous close


$3.1900

Volume


23.4K

Market cap


$8.51M

Day range


$3.0200 - $3.3650

52 week range


$1.2700 - $9.4699

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Dec 17, 2024
4 Insider transactions 1 Nov 25, 2024
10-q Quarterly Reports 63 Nov 14, 2024
4 Insider transactions 1 Aug 07, 2024
10-q Quarterly Reports 63 Aug 07, 2024
8-k 8K-related 15 Aug 07, 2024
8-k 8K-related 13 Jun 14, 2024
10-q Quarterly Reports 62 May 07, 2024
def Proxies and info statements 4 Apr 29, 2024
8-k 8K-related 13 Apr 18, 2024

Latest News